Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,786
Closed -$310K 1284
2023
Q2
$310K Hold
5,786
﹤0.01% 981
2023
Q1
$310K Sell
5,786
-563
-9% -$30.7K ﹤0.01% 986
2022
Q4
$434K Buy
+6,349
New +$427K ﹤0.01% 869
2020
Q4
Sell
-53
Closed 1369
2020
Q3
$0 Hold
53
﹤0.01% 2468
2020
Q2
$0 Buy
+53
New +$608 ﹤0.01% 2458
2014
Q3
Sell
-20,305
Closed -$166K 2460
2014
Q2
$166K Sell
20,305
-15,437
-43% -$126K ﹤0.01% 1233
2014
Q1
$301K Hold
35,742
﹤0.01% 1046
2013
Q4
$344K Buy
+35,742
New +$382K ﹤0.01% 977
2013
Q3
Sell
-27,082
Closed -$273K 2213
2013
Q2
$273K Buy
+27,082
New +$252K ﹤0.01% 989

Other funds holding CALX

Glenmede Trust's CALX Position: Q3 2023 in Review

Glenmede Trust sold out of Calix (CALX) in Q3 2023, closing a stake of 5,786 shares — an estimated $310K sold.

Glenmede Trust first reported a position in CALX in Q2 2013 and held it in 9 quarters. The position peaked at $434K in Q4 2022. 276 funds tracked by Wall St. Rank hold CALX as of Q3 2023.

  • Glenmede Trust reported no remaining Calix position as of Q3 2023 after selling out during the quarter.
  • Glenmede Trust sold 5,786 Calix shares in Q3 2023, an estimated $310K.
  • Glenmede Trust first reported a position in Calix in Q2 2013 and held it in 9 quarters.
  • Glenmede Trust's Calix position peaked at $434K in Q4 2022.
  • 276 funds tracked by Wall St. Rank held Calix as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.